Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Aerie Pharmaceuticals Inc.

www.aeriepharma.com

Latest From Aerie Pharmaceuticals Inc.

Finance Watch: Five IPOs Launch In Two Days; Three Remain In Positive Territory

Public Company Edition: Trevi Therapeutics was the first out of the gate on 7 May, but four more biopharma firms went public in the US on 8 May, while just 13 IPOs launched between January and April. Also, new financings include debt for BMS, Bausch and Intercept.

Financing Business Strategies

Purple Patch For Pharma/Biotech R&D As NAS Launches Reach Record High

The pharma and biotech industries enjoyed their most productive year since the turn of the century in terms of number of novel products launched worldwide in 2018.

Launches Analysis

Keeping Track: Two Goal Date Extensions, Another Herceptin Biosimilar Approval, And A BLA Withdrawal

The latest drug development news and highlights from our US FDA Performance Tracker.
Drug Review Regulation

Aerie Looks To Grow Its Two Glaucoma Products In Tandem

The approval of combo therapy Rocklatan gives Aerie two approved glaucoma products; Rhopressa quickly attained wide market access in the US and Aerie expects Rocklatan to fare the same.

Approvals Business Strategies
See All

Company Information

  • Industry
  • Biotechnology
  • Medical Devices
    • Biomaterials
    • Implantable Devices
  • Pharmaceuticals
  • Therapeutic Areas
  • Ophthalmic
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Aerie Pharmaceuticals Inc.
  • Senior Management
  • Vincente, Jr. Anido, PhD , Chmn. & CEO
    Richard J Rubino, CFO
    Casey C Kopczynski, PhD, CSO
    Judith J Robertson, Chief Commercial Officer
    Richard Lewis, MD, CMO
    Eric Carlson, PhD, VP, R&D
  • Contact Info
  • Aerie Pharmaceuticals Inc.
    Phone: (949) 526-8700
    2030 Main St., Ste. 1500
    Irvine, CA 92614
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register